Application of BactTiter-Glo ATP bioluminescence assay for Mycobacterium tuberculosis detection
Copyright © 2024. Published by Elsevier Inc..
BACKGROUND: Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), remains a global health threat, necessitating faster and more accessible diagnostic methods. This study investigates critical parameters in the application of a commercial ATP bioluminescence assay for the detection of MTB.
METHOD: Our objective was to optimize the ATP bioluminescence protocol using BacTiter-Glo™ for MTB, investigating the impact of varying volumes of MTB suspension and reagent on assay sensitivity, evaluating ATP extraction methods, establishing calibration curves, and elucidating strain-specific responses to antimicrobial agents.
RESULTS: ATP extraction methods showed no significant improvement over controls. Calibration curves revealed a linear correlation between relative light units (RLU) and colony-forming units (CFU/mL), establishing low detection limits. Antimicrobial testing demonstrated strain-specific responses aligning with susceptibility and resistance patterns.
CONCLUSION: Our findings contribute to refining ATP bioluminescence protocols for enhanced MTB detection and susceptibility testing. Further refinements and validation efforts are warranted, holding promise for more efficient diagnostic platforms in the future.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:109 |
---|---|
Enthalten in: |
Diagnostic microbiology and infectious disease - 109(2024), 2 vom: 27. Apr., Seite 116275 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Abou Mourad Ferreira, Mariana [VerfasserIn] |
---|
Links: |
---|
Themen: |
8L70Q75FXE |
---|
Anmerkungen: |
Date Completed 28.04.2024 Date Revised 28.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.diagmicrobio.2024.116275 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370270509 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370270509 | ||
003 | DE-627 | ||
005 | 20240429232114.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240329s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.diagmicrobio.2024.116275 |2 doi | |
028 | 5 | 2 | |a pubmed24n1392.xml |
035 | |a (DE-627)NLM370270509 | ||
035 | |a (NLM)38537505 | ||
035 | |a (PII)S0732-8893(24)00104-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Abou Mourad Ferreira, Mariana |e verfasserin |4 aut | |
245 | 1 | 0 | |a Application of BactTiter-Glo ATP bioluminescence assay for Mycobacterium tuberculosis detection |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.04.2024 | ||
500 | |a Date Revised 28.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024. Published by Elsevier Inc. | ||
520 | |a BACKGROUND: Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), remains a global health threat, necessitating faster and more accessible diagnostic methods. This study investigates critical parameters in the application of a commercial ATP bioluminescence assay for the detection of MTB | ||
520 | |a METHOD: Our objective was to optimize the ATP bioluminescence protocol using BacTiter-Glo™ for MTB, investigating the impact of varying volumes of MTB suspension and reagent on assay sensitivity, evaluating ATP extraction methods, establishing calibration curves, and elucidating strain-specific responses to antimicrobial agents | ||
520 | |a RESULTS: ATP extraction methods showed no significant improvement over controls. Calibration curves revealed a linear correlation between relative light units (RLU) and colony-forming units (CFU/mL), establishing low detection limits. Antimicrobial testing demonstrated strain-specific responses aligning with susceptibility and resistance patterns | ||
520 | |a CONCLUSION: Our findings contribute to refining ATP bioluminescence protocols for enhanced MTB detection and susceptibility testing. Further refinements and validation efforts are warranted, holding promise for more efficient diagnostic platforms in the future | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a ATP | |
650 | 4 | |a Bioluminescence assay | |
650 | 4 | |a Detection | |
650 | 4 | |a Mycobacterium tuberculosis | |
650 | 4 | |a Tuberculosis | |
650 | 7 | |a Adenosine Triphosphate |2 NLM | |
650 | 7 | |a 8L70Q75FXE |2 NLM | |
700 | 1 | |a Candeias Dos Santos, Laura |e verfasserin |4 aut | |
700 | 1 | |a Schmidt Castellani, Luiz Guilherme |e verfasserin |4 aut | |
700 | 1 | |a Negrelli Brunetti, Manuela |e verfasserin |4 aut | |
700 | 1 | |a Palaci, Moisés |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diagnostic microbiology and infectious disease |d 1986 |g 109(2024), 2 vom: 27. Apr., Seite 116275 |w (DE-627)NLM01262845X |x 1879-0070 |7 nnns |
773 | 1 | 8 | |g volume:109 |g year:2024 |g number:2 |g day:27 |g month:04 |g pages:116275 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.diagmicrobio.2024.116275 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 109 |j 2024 |e 2 |b 27 |c 04 |h 116275 |